Fountain Healthcare Partners
48
29M
26
3.00
13
0.46
7
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Dublin. The fund was located in Europe if to be more exact in Ireland.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Fountain Healthcare Partners, startups are often financed by Enterprise Ireland, Seroba Life Sciences, Longitude Capital. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, Novartis Venture Fund, Longitude Capital. In the next rounds fund is usually obtained by Enterprise Ireland, Sunstone Life Science Ventures, Roche Venture Fund.
Among the various public portfolio startups of the fund, we may underline Inflazome, Opsona, Amarin For fund there is a match between the country of its foundation and the country of its the most frequent investments - Ireland. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biopharma. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The current fund was established by Aidan King, Manus Rogan. The overall number of key employees were 4.
The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations. When the investment is from Fountain Healthcare Partners the average startup value is 50-100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Fountain Healthcare Partners performs on 10 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 48
- Lead investments
- 13
- Exits
- 7
- Rounds per year
- 3.00
- Follow on index
- 0.46
- Investments by industry
- Health Care (40)
- Biotechnology (36)
- Medical (27)
- Medical Device (23)
- Therapeutics (11) Show 12 more
- Investments by region
-
- Ireland (27)
- United States (7)
- Italy (3)
- Belgium (4)
- United Kingdom (3) Show 2 more
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 57M
- Group Appearance index
- 0.90
- Avg. company exit year
- 7
- Avg. multiplicator
- 6.33
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
MMI | 21 Feb 2024 | Health Care, Robotics, Medical Device, Medical | Late Stage Venture | 110M | Tuscany, Italy, Italy |
Syndesi Therapeutics | 28 Sep 2020 | Biotechnology, Health Care | Early Stage Venture | 7M | Limburg, Belgium, Belgium |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.